Can a new tracer light up hidden prostate cancer?
Diagnosis
Not yet recruiting
This trial is testing an experimental imaging agent called [⁶⁴Cu]Cu-RAX301, which is designed to bind to prostate cancer cells and show up on PET/CT scans. The study includes men with prostate cancer who are either about to have surgery to remove the prostate or who may have a re…
Phase: PHASE1, PHASE2 • Sponsor: RadAlliance Therapeutics, Inc • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC